工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor infiltrating lymphocytes against solid tumors: current trends & perspectives.
Tumor infiltrating lymphocytes against solid tumors: current trends & perspectives.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
TIL(肿瘤浸润淋巴细胞)是抗癌免疫的重要组成部分,也是癌症进展的重要预后因素。本综述讨论TIL不同细胞群的最新研究进展及其在肿瘤免疫中的作用。肿瘤微环境(TME)中抗肿瘤与促肿瘤免疫细胞的存在及其平衡,在很大程度上决定肿瘤的进展和结局。因此,本文回顾TIL的特性,以加深对这些免疫细胞在TME中作用的认识;同时介绍影响实体瘤免疫细胞浸润的多种因素,为改善TIL浸润、提高临床结局提出新的免疫治疗思路,并将近期策略归纳为建议。总体而言,本综述强调TIL的关键作用、决定免疫细胞归巢与浸润的因素,以及改善TIL浸润的策略。
Tumor-infiltrating lymphocytes (TILs) are recognized as a key component of anticancer immunity and serve as an important prognostic factor in cancer progression. In this review, the latest updates and perspectives on the diverse populations of TILs and their roles in cancer immunity are discussed. The presence and balance between anti-tumorigenic and pro-tumorigenic immune cells in the tumor microenvironment (TME) largely determine tumor progression and fate.
Thus, the properties of TILs were reviewed to provide a better insight into the roles of these immune cells within the TME.
Additionally, the different factors influencing immune cell infiltration in solid tumors are also described to suggest novel immunotherapeutic approaches for improved TIL infiltration. These recent approaches are then summarised as recommendations to improve infiltration and potentially achieve better clinical outcomes.
Overall, this review highlights the critical role of TILs, factors governing immune cell homing and infiltration, and strategic approaches to improve TIL infiltration.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。